Mikael Dolsten - Director at Karyopharm Therapeutics Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
KPTI on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Mikael Dolsten since 27 Aug 2025

Reported holdings for Mikael Dolsten in Karyopharm Therapeutics Inc.

Form 4 holding Director

Karyopharm Therapeutics Inc.

Security class
Nonstatutory Stock Option (right to buy)
Shares / value
23,900
Estimated value
Report date
21 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Mikael Dolsten in Karyopharm Therapeutics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .